Overview of systematic reviews on Chinese patented oral medicines for promoting blood circulation and removing blood stasis combined with western medicine in the treatment of coronary heart disease angina pectoris
Despite the demonstrated efficacy and safety of Chinese patented oral medicines that promote blood circulation and remove blood stasis in the adjuvant treatment of angina pectoris, the low methodological and reporting quality of current systematic reviews and meta-analyses compromises the reliability of these findings. Future research should focus on standardizing study design and reporting to improve the reliability of evidence.
Authors
- Yi‐Mo Deng (ORCID: https://orcid.org/0000-0003-2177-8308)
- Yan‐Ming Xie (ORCID: https://orcid.org/0000-0001-5359-4242)
- Junjie Jiang (ORCID: https://orcid.org/0000-0001-5011-0118)
- Wen-Xi Peng (ORCID: https://orcid.org/0000-0002-7453-9709)
- Hongli Wu (ORCID: https://orcid.org/0000-0001-6632-3118)
- Huan Liu (ORCID: https://orcid.org/0000-0001-5778-9370)
- Xinyi Chen (ORCID: https://orcid.org/0000-0002-3511-8733)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-06-20
- DOI
- https://doi.org/10.3389/fcvm.2025.1553735
- Primary Topic
- Traditional Chinese Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- China Academy of Chinese Medical Sciences